{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:55:26Z","timestamp":1785430526320,"version":"3.56.0"},"reference-count":45,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir. j. psychol. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0790966726101748_as1\">\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Dual disorder, comprising of substance use and mental health disorders, requires a comprehensive treatment approach. The most effective is integrated dual disorder treatment, which involves addressing both conditions concurrently by the same specialists and in the same setting. This study examines characteristics of integrated dual disorder care offered by treatment services across European countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0790966726101748_as2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In 2022, representatives of 14 integrated care for dual disorder providers in 10 European countries were asked to respond to a survey about their treatment process, outcomes, barriers and facilitators when implementing dual disorder treatment in respective countries. Thematic qualitative analysis was used to explore closed- and open-ended responses, focusing on commonalities and differences between surveyed services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0790966726101748_as3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Integrated care services varied in treatment settings and structure, but all offered comprehensive support for dual disorder. Among 14 services, half addressed tobacco addiction or provided suicide prevention, three treated cannabis use, and none accepted patients in opioid agonist therapy. Few services reported evaluating treatment outcomes in standardised way. Services supported patients with social security, employment, housing and education, but also noted difficulties in coordinating post-treatment care due to divergent views on dual disorder among specialists from different services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0790966726101748_as4\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Integrated care services provide comprehensive and tailored support for people with dual disorder but remain distinct within the healthcare options available to this patient group across Europe. Existing and future integrated care services would benefit from addressing tobacco and cannabis use, measuring treatment outcomes and improving continuity of care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/ipm.2026.10174","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T03:25:22Z","timestamp":1774236322000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Integrated treatment approaches for co-occurring mental health and substance use disorders: findings from a survey of European healthcare providers"],"prefix":"10.1017","author":[{"given":"Francina","family":"Fonseca","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03a8gac78","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital del Mar"},{"id":[{"id":"https:\/\/ror.org\/042nkmz09","id-type":"ROR","asserted-by":"publisher"}],"name":"Institut Hospital del Mar d\u2019Investigacions M\u00e8diques (IMIM)"},{"id":[{"id":"https:\/\/ror.org\/04n0g0b29","id-type":"ROR","asserted-by":"publisher"}],"name":"Universitat Pompeu Fabra"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6323-3659","authenticated-orcid":false,"given":"Erikas","family":"Simonavi\u010dius","sequence":"additional","affiliation":[{"name":"European Union Drugs Agency (EUDA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bo","sequence":"additional","affiliation":[{"name":"European Union Drugs Agency (EUDA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Vandam","sequence":"additional","affiliation":[{"name":"European Union Drugs Agency (EUDA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Ferri","sequence":"additional","affiliation":[{"name":"European Union Drugs Agency (EUDA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinta","family":"Manche\u00f1o","sequence":"additional","affiliation":[{"name":"University of Huelva"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Hasselberg","sequence":"additional","affiliation":[{"name":"Universidade do Minho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan-I","family":"Mestre-Pint\u00f3","sequence":"additional","affiliation":[{"name":"Hospital del Mar Research Institute, Barcelona, Spain Law Department, Universitat Pompeu Fabra, Barcelona, Spain Red de Investigaci\u00f3n en Atenci\u00f3n Primaria en Adicciones (RIAPAd) Ines Hasselberg: European Union Drugs Agency (EUDA)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Torrens","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03a8gac78","id-type":"ROR","asserted-by":"publisher"}],"name":"Hospital del Mar"},{"id":[{"id":"https:\/\/ror.org\/042nkmz09","id-type":"ROR","asserted-by":"publisher"}],"name":"Institut Hospital del Mar d\u2019Investigacions M\u00e8diques (IMIM)"},{"id":[{"id":"https:\/\/ror.org\/04n0g0b29","id-type":"ROR","asserted-by":"publisher"}],"name":"Universitat Pompeu Fabra"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Montanari","sequence":"additional","affiliation":[{"name":"European Union Drugs Agency (EUDA)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"S0790966726101748_ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s001270170030"},{"key":"S0790966726101748_ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02212-5"},{"key":"S0790966726101748_ref31","first-page":"259","article-title":"Secondary cannabis use among London drug treatment service clients","volume":"26","author":"Simonavicius","year":"2019","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"S0790966726101748_ref40","unstructured":"UNODC (2022) Comorbidities in drug use Disorders. No Wrong Door. Available at: https:\/\/www.unodc.org\/unodc\/drug-prevention-and-treatment\/publications\/data\/2022\/march\/comorbidities-in-drug-use-disorders-no-wrong-door.html (accessed 15 September 2025)."},{"key":"S0790966726101748_ref41","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20796"},{"key":"S0790966726101748_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0755-0"},{"key":"S0790966726101748_ref27","unstructured":"NIDA 2020) Common Comorbidities with Substance use Disorders Research Report. PubMed [Preprint]. National Institutes on Drug Abuse."},{"key":"S0790966726101748_ref37","volume-title":"Te Ariari O Te Oranga: The Assessment and Management of People with Co-existing Mental Health and Substance Use Problems, 2010","author":"Todd","year":"2010"},{"key":"S0790966726101748_ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13040999"},{"key":"S0790966726101748_ref5","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2025.2557191"},{"key":"S0790966726101748_ref10","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.4.324"},{"key":"S0790966726101748_ref12","doi-asserted-by":"publisher","DOI":"10.1111\/add.70125"},{"key":"S0790966726101748_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpra.2022.05.005"},{"key":"S0790966726101748_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(18)30052-5"},{"key":"S0790966726101748_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.02.003"},{"key":"S0790966726101748_ref26","unstructured":"National Working Group for Dual Diagnosis (2023) Model of Care for People with Mental Disorder and Co-Existing Substance use Disorder (Dual Diagnosis). Available at: https:\/\/www.hse.ie\/eng\/about\/who\/cspd\/%0Ancps\/mental-health\/dual-diagnosis-ncp\/ (accessed 15 September 2025)."},{"key":"S0790966726101748_ref33","doi-asserted-by":"publisher","DOI":"10.1080\/17523281003733514"},{"key":"S0790966726101748_ref35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1151"},{"key":"S0790966726101748_ref38","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2012.663296"},{"key":"S0790966726101748_ref25","unstructured":"Montanari, L , Fonseca, F , Auriacombe, M , Baldaccino, A , Bo, A , Fischer, G , Hasselberg, I , Kastelic, A , Kokkolis, K , Mallori, M , Mestre, J , Migchels, C , Simonavicus, E , Subramanian, N , Vandam, L , Mancheno-Velasco, C , Willy-Lie, T , Whyte, A , Farri, M and Torrens, M (2026) Mental Health and Substance use in Europe: Towards a Common European Approach. Irish Journal of Psychological Medicine. In press [Preprint]."},{"key":"S0790966726101748_ref42","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21073"},{"key":"S0790966726101748_ref4","first-page":"71","article-title":"Tratamiento coordinado entre centros de adicciones y salud mental vs. tratamiento no coordinado para pacientes con patolog\u00eda dual: mayor abandono, pero menor deterioro de la discapacidad funcional","volume":"49","author":"Barba","year":"2021","journal-title":"Actas Espa\u00f1olas De Psiquiatr\u00eda"},{"key":"S0790966726101748_ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-017-0800-3"},{"key":"S0790966726101748_ref39","doi-asserted-by":"publisher","DOI":"10.4321\/S1575-06202019000300006"},{"key":"S0790966726101748_ref14","doi-asserted-by":"publisher","DOI":"10.1037\/adb0000330"},{"key":"S0790966726101748_ref18","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11050639"},{"key":"S0790966726101748_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.111017"},{"key":"S0790966726101748_ref22","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2015.1104930"},{"key":"S0790966726101748_ref28","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdv148"},{"key":"S0790966726101748_ref9","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12475"},{"key":"S0790966726101748_ref11","unstructured":"Council of the EU (2023) Council Addresses Situation of People Suffering from both Drug use and other Mental Health Disorders. Available at: https:\/\/www.consilium.europa.eu\/en\/press\/press-releases\/2023\/12\/05\/council-addresses-situation-of-people-suffering-from-both-drug-use-and-other-mental-health-disorders (accessed 15 September 2025)."},{"key":"S0790966726101748_ref3","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2016.1254309"},{"key":"S0790966726101748_ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0020764019899975"},{"key":"S0790966726101748_ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-018-0970-7"},{"key":"S0790966726101748_ref7","doi-asserted-by":"publisher","DOI":"10.1111\/add.12269"},{"key":"S0790966726101748_ref20","doi-asserted-by":"publisher","DOI":"10.1111\/add.70140"},{"key":"S0790966726101748_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2018.10.014"},{"key":"S0790966726101748_ref16","unstructured":"EUDA (2025) European drug report 2025: Trends and Developments. Available at: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2025_en (accessed 15 September 2025)."},{"key":"S0790966726101748_ref19","doi-asserted-by":"publisher","DOI":"10.4324\/9781003128571"},{"key":"S0790966726101748_ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/509864"},{"key":"S0790966726101748_ref30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0043-102059","article-title":"New psychoactive substances (NPS)\u2013a challenge for the addiction treatment services","volume":"50","author":"Scherbaum","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"S0790966726101748_ref1","doi-asserted-by":"publisher","DOI":"10.62641\/aep.v53i2.1835"},{"key":"S0790966726101748_ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-012-0449-1"},{"key":"S0790966726101748_ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00569"},{"key":"S0790966726101748_ref13","unstructured":"EMCDDA (2015) Comorbidity of Substance use and Mental Disorders in Europe. Available at: https:\/\/data.europa.eu\/doi\/10.2810\/532790 (accessed 15 September 2025)."}],"container-title":["Irish Journal of Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0790966726101748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T03:25:29Z","timestamp":1774236329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0790966726101748\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":45,"alternative-id":["S0790966726101748"],"URL":"https:\/\/doi.org\/10.1017\/ipm.2026.10174","relation":{},"ISSN":["0790-9667","2051-6967"],"issn-type":[{"value":"0790-9667","type":"print"},{"value":"2051-6967","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}